Effect of Sofosbuvir-daclatasuvir on Angiogenesis

Sherief Abd-Elsalam40 enrolled

Overview

The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection

The study primary aim was at evaluation of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sofosbuvir-daclatasvir for 3 months

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Chronic HCV patients Exclusion Criteria: * HCC. * HIV or HBV. * Malignancy. * Pregnancy.

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Number of patients with change in VEGF, TGFB1

Time frame: 6 months

Sherief Abd-Elsalam, MD

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.